Spinal Implant Premarket Trial Times Could Be Cut By Postmarket Study - FDA
This article was originally published in The Gray Sheet
Executive Summary
Use of well-crafted postmarket studies of spinal implant devices could decrease the length of the premarket trial, FDA suggests in a recently released draft guidance on the preparation of investigational device exemptions for spinal assemblies.